Clinical trial
Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Healthy Blood Donors
NCT01277549 is registered in ClinicalTrials.gov with Terumo BCT as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Spectra Optia® Apheresis System Mononuclear Cell (MNC) Collection Procedure in Healthy Blood Donors
- Lead sponsor
- Terumo BCT
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- September 30, 2011
- Enrollment
- 71 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
leukapheresis